Axonal neurofilaments are nonessential elements of toxicant-induced reductions in fast axonal transport: Video-enhanced differential interference microscopy in peripheral nervous system axons

Toxicology and Applied Pharmacology

Volumn 161, Issue 1, 1999, Pages 50-58

  Stone, J Derek ^a   Peterson, Alan P ^b   Eyer, Joel ^c   Oblak, T Gregory ^a   Sickles, Dale W ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

2,5 hexanedione; Acrylamide; Fast axonal transport; Neurofilaments; Peripheral nervous system

Indexed keywords

ACETONYLACETONE; ACRYLAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; MOLECULAR DYNAMICS; MOUSE; NERVE FIBER TRANSPORT; NEUROFILAMENT; NEUROTOXICITY; NONHUMAN; PHASE CONTRAST MICROSCOPE; SCIATIC NERVE; TRANSGENIC MOUSE; TRANSPORT KINETICS;

ANIMALIA; MUS MUSCULUS;

EID: 0033571227     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1999.8780     Document Type: Article

References (62)

1. Allen N., Mendall J. R., Billmaier D. J., Fontaine R. E., O'Neill J. Toxic polyneuropathy due to methyl n-butyl ketone. Arch. Neurol. 32:1975;209-218.
2. Allen R. D., Allen N. S., Travis J. L. Video-enhanced contrast, differential interference contrast (AVEC-DIC) microscopy: A new method capable of analyzing microtubule-related motility in the reticulopodial network of Allogromia laticollaris. Cell Motil. 1:1981;291-302.
3. Anthony D. C., Boekelheide K., Graham D. G. The effect of 3,4-dimethyl substitution on the neurotoxicity of 2,5-hexanedione. I. Accelerated clinical neuropathy is accompanied by more proximal axonal swellings. Toxicol. Appl. Pharmacol. 71:1983a;362-371.
4. Auld R. B., Bedwell S. F. Peripheral neuropathy with sympathetic overactivity from industrial contact with acrylamide. Can. Med. Assoc. J. 96:1967;652-654.
5. Brady S. T., Lasek R. J., Allen R. D. Video microscopy of fast axonal transport in extruded axoplasm: A new model for study of molecular mechanisms. Cell Motil. 5:1985;81-101.
6. Brady S. T., Pfister K. K., Bloom G. S. A monoclonal antibody against kinesin inhibits both anterograde and retrograde fast axonal transport in squid axoplasm. Proc. Natl. Acad. Sci. USA. 87:1990;1061-1065.
7. Brat D. J., Brimijoin S. Acrylamide and glycidamide impair outgrowth in differentiating N1E.115 neuroblastoma without disturbing rapid bi-directional transport of organelles observed by video microscopy. J. Neurochem. 60:1993;2145-2152.
8. Cavanagh J. B. The significance of the "dying-back" process in experimental and human neurological disease. Int. Rev. Exp. Pathol. 3:1964;219-267.
9. Clarke C. H., Sickles D. W. Decreased GAP-43 accumulation in neurite tips of cultured hippocampal neurons by acrylamide. Neurotoxicology. 17:1996;397-406.
10. DeCaprio A. P. Molecular mechanisms of diketone neurotoxicity. Chem.-Biol. Interact. 54:1985;257-270.
11. DeCaprio A. P., Olajos E. J., Weber P. Covalent binding of a neurotoxic n-hexane metabolite: Conversion of primary amines to substituted pyrrole adducts by 2,5-hexanedione. Toxicol. Appl. Pharmacol. 65:1982;440-450.
12. Eyer J., Peterson A. Neurofilament-deficient axons and perikaryal aggregates in viable transgenic mice expressing a neurofilament-β-galactosidase fusion protein. Neuron. 12:1994;1-20.
13. Garland T. O., Patterson M. W. H. Six cases of acrylamide poisoning. Br. Med. J. 10/21:1967;134-138.
14. Grafstein B. The nerve cell response to axotomy. Exp. Neurol. 48:1975;32-51.
15. Graham D. G. Hexane neuropathy: A proposal for pathogenesis of a hazard of occupational exposure and inhalant abuse. Chem.-Biol. Interact. 32:1980;339-345.
16. Graham D. G., Anthony D. C., Boekelheide K. In vitro and in vivo studies of the molecular pathogenesis of n-hexane neuropathy. Neurobehav. Toxicol. Teratol. 4:1982;629-634.
17. Graham D. G., Szakal-Quin G., Priest J. W., Anthony D. C. In vitro evidence that covalent crosslinking of neurofilaments occurs in gamma-diketone neuropathy. Proc. Natl. Acad. Sci. USA. 81:1984;4979-4982.
18. Griffin J. W. Axonal transport in neurotoxic disorders. Comments Toxicol. 3:1989;405-426.
19. Griffin J. W., Hoffman P. N., Clark A. W., Carroll P. T., Price D. L. Slow axonal transport of neurofilament proteins: Impairment by β,β′-iminodipropionitrile administration. Science. 202:1978;633-635.
20. Harris C. H., Gulati A. K., Friedman M. A., Sickles D. W. Toxic neurofilamentous axonopathies and fast anterograde axonal transport. V. Reduced bi-directional vesicle transport in cultured neurons by acrylamide and glycidamide. J. Toxicol. Environ. Health. 42:1994;343-356.
21. Harry G. J., Goodrum J. F., Bouldin T. W., Toews A. D., Morell P. Acrylamide-induced increases in deposition of axonally transported glycoproteins in rat sciatic nerve. J. Neurochem. 52:1989;1240-1247.
22. Hendry I. A., Stach R., Herrup K. Characteristics of the retrograde axonal transport system for nerve growth factor in the sympathetic nervous system. Brain Res. 82:1974;117-128.
23. Hirokawa N. Kinesin and dynein superfamily proteins and the mechanism of organelle transport. Science. 279:1998;519-526.
24. Jakobsen J., Sidenius P. Early and dose dependent decrease of retrograde axonal transport in acrylamide intoxicated rats. J. Neurochem. 40:1983;447-454.
25. Korobkin R., Asbury A. K., Summer A. J., Nielsen S. L. Glue-sniffing neuropathy. Arch. Neurol. 32:1975;158-162.
26. Kristensson K., Gustafsson M. Toxic actions on axonal transport mechanisms. Acta Neurol. Scand. 70:1984;27-32.
27. Lehning E. J., Persaud A., Dyer K. R., Jortner B. S., LoPachin R. M. Biochemical and morphologic characterization of acrylamide peripheral neuropathy. Toxicol. Appl. Pharmacol. 151:1998;211-221.
28. Logan M. J., McLean W. G. A comparison of the effects of acrylamide and experimental diabetes on the retrograde axonal transport of proteins in the rat sciatic nerve: Analysis by two-dimensional polyacrylamide gel. J. Neurochem. 50:1988;183-189.
29. Martenson C. H., Anthony D. C., Sheetz M. P., Graham D. G. A quantitation of fast axonal transport in cultured chick dorsal root ganglion (DRG) explants following exposure to acrylamide (ACR), methacrylamide (M-ACR) and cyanide. Toxicologist. 12:1992;191.
30. Martenson C. H., Odom A., Sheetz M. P., Graham D. G. The effect of acrylamide and other sulfhydryl alkylators on the ability of dynein and kinesin to translocate microtubules in vitro. Toxicol. Appl. Pharmacol. 133:1995;73-81.
31. Miller M. S., Miller M. J., Burks T. F., Sipes I. G. Altered retrograde axonal transport of nerve growth factor after single and repeated doses of acrylamide in the rat. Toxicol. Appl. Pharmacol. 69:1983;96-101.
32. Miller M. S., Spencer P. S. Single doses of acrylamide reduce retrograde transport velocity. J. Neurochem. 43:1984;1401-1408.
33. Miller M. S., Spencer P. S. The mechanisms of acrylamide axonopathy. Annu. Rev. Pharmacol. Toxicol. 25:1985;643-666.
34. Moretto A., Sabri M. I. Progressive deficits in retrograde axon transport precede degeneration of motor axons in acrylamide neuropathy. Brain Res. 440:1988;18-24.
35. Padilla S., Atkinson M. B., Breuer A. C. Direct measurement of fast axonal organelle transport in the sciatic nerve of rats treated with acrylamide. J. Toxicol. Environ. Health. 39:1993;429-445.
36. Papasozemenos S. C. H., Yoon M., Crane R., Autilio-Gambetti L. Redistribution of proteins of fast axonal transport following administration of β,β′-iminodipropionitrile: A quantitative autoradiographic study. J. Cell Biol. 95:1982;672-675.
37. Paschal B. M., Vallee R. B. Retrograde transport by the microtubule associated protein MAP 1C. Nature. 330:1987;181-183.
38. Pfister K. K., Wagner M. C., Bloom G. S., Brady S. T. Modification of the microtubule-binding and ATPase activities of kinesin by N-ethylmaleimide (NEM) suggests a role of sulfhydryls in fast axonal transport. Biochemistry. 28:1989;9006-9012.
39. Prineas J. The pathogensis of dying-back polyneuropathies. Part 2. An ultrastructural study of experimental acrylamide intoxication in the cat. J. Neuropathol. Exp. Neurol. 28:1969;598-621.
40. Raymer J. H., Sparacino C. M., Velez G. R., Padilla S., MacPhail R. C., Crofton K. M. Determination of acrylamide in rat serum and sciatic nerve by gas chromatography-electron-capture detection. J. Chromatogr. 619:1993;223-234.
41. Redenbach D. M., Richburg J. H., Boekelheide K. Microtubules with altered assembly kinetics have a decreased rate of kinesin-based transport. Cell Motil. Cytoskel. 26:1993;79-87.
42. Sahenk Z., Mendell J. R. Acrylamide and 2,5-hexanedione neuropathies: Abnormal bi-directional transport rate in distal axons. Brain Res. 219:1981;397-405.
43. Sayre L. M., Autilio-Gambetti L., Gambetti P. Pathogenesis of experimental giant neurofilamentous axonopathies: A unified hypothesis based on chemical modification of neurofilaments. Brain Res. Rev. 10:1985;69-83.
44. Schaumburg H. H., Wisniewski H. M., Spencer P. S. Ultrastructural studies of the dying-back process. I. Peripheral nerve terminal and axon degeneration in systemic acrylamide intoxication. J. Neuropathol. Exp. Neurol. 33:1974;260-284.
45. Sickles D. W. Toxic neurofilamentous axonopathies and fast anterograde axonal transport. I. The effects of single doses of acrylamide on the rate and capacity of transport. Neurotoxicology. 10:1989a;91-102.
46. Sickles D. W. Toxic neurofilamentous axonopathies and fast anterograde axonal transport. II. The effects of single doses of neurotoxic and non-neurotoxic diketones and β,β′-iminodipropionitrile (IDPN) on the rate and capacity of transport. Neurotoxicology. 10:1989b;103-112.
47. Sickles D. W. Toxic neurofilamentous axonopathies and fast anterograde axonal transport. III. Recovery from single injections and multiple dosing effects of acrylamide and 2,5-hexanedione. Toxicol. Appl. Pharmacol. 108:1991;390-396.
48. Sickles D. W. Toxic neurofilamentous axonopathies and fast anterograde axonal transport. IV. In vitro analysis of transport following acrylamide and 2,5-hexanedione. Toxicol. Lett. 61:1992;199-204.
49. Sickles D. W., Brady S. T., Testino A., Friedman M. A., Wrenn R. A. Direct effect of the neurotoxicant acrylamide on kinesin-based microtubule motility. J. Neurosci. Res. 46:1996;7-17.
50. Sickles, D. W, Stone, J. D, and, Friedman, M. A. 1999, Fast axonal transport: A site of acrylamide neurotoxicity?, (submitted for publication).
51. Sickles D. W., Tsai J. 2,5-Hexanedione directly affects kinesin-based microtubule motility. Toxicologist. 30:1996;302.
52. Sickles D. W., Tsai N., Padilla S. Acrylamide produces a temporal and correlative decrease in fast anterogradely transported proteins in neuromuscular junctions. Toxicologist. 37:1998;107.
53. Sidenius P., Jakobsen J. Anterograde axonal transport in rats during intoxication with acrylamide. J. Neurochem. 40:1983;697-704.
54. Spencer P. S., Bischoff M. C., Schaumburg H. H. On the specific molecular configuration of neurotoxic aliphatic hexacarbon compounds causing central-peripheral distal axonopathy. Toxicol. Appl. Pharmacol. 44:1978;17-28.
55. Spencer P. S., Schaumburg H. H. A review of acrylamide neurotoxicity Part 1. Properties, uses and human exposure. Can. J. Neurol. Sci. 1:1974;143-150.
56. Spencer P. S., Schaumburg H. H. Central-peripheral distal axonopathy - The pathology of dying-back polyneuropathies. Prog. Neuropathol. 3:1976;253-295.
57. Spencer P. S., Schaumburg H. H. Ultrastructural studies of the dying back process. IV. Differential vulnerability of PNS and CNS fibers in experimental central-peripheral distal axonopathies. J. Neuropathol. Exp. Neurol. 36:1977;300-320.
58. Spencer P. S., Schaumburg H. H., Raleigh R. L., Terhaar C. J. Nervous system degeneration produced by the industrial solvent methyl n-buthyl ketone. Arch. Neurol. 32:1975;219-222.
59. Stone, J. D, Peterson, A. P, Eyer, J, Oblak, T. G, and, Sickles, D. W. 1999a, Axonal neurofilaments are non-essential elements in the pathogenesis of mammalian toxic neuropathies. (submitted for publication).
60. Stone J. D., Peterson A. P., Eyer J., Sickles D. W. Axonal neurofilaments are non-essential elements of toxicant-induced reductions in fast axonal transport I. Radiolabeling in CNS axons. Neurotoxicology. 1999b.
61. Sumner A., Pleasure D. E., Ciesielka K. Slowing of fast axoplasmic transport in acrylamide neuropathy. J. Neuropathol. Exp. Neurol. 35:1976;319.
62. Weir R. L., Glaubiger G., Chase T. N. Inhibition of fast axoplasmic transport by acrylamide. Environ. Res. 17:1978;251-255.